<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02430142</url>
  </required_header>
  <id_info>
    <org_study_id>2014-428M-MA</org_study_id>
    <nct_id>NCT02430142</nct_id>
  </id_info>
  <brief_title>Microcirculatory Oxygen Uptake in Sepsis</brief_title>
  <official_title>Microcirculatory Oxygen Uptake in Sepsis, Severe Sepsis and Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Forearm vasoocclusive testing (VOT) will be performed with laser-doppler spectrophotometry
      system in septic patients on ICU. Microcirculatory oxygen uptake will be checked for
      prognostic value and for associations with tissue hypoxia markers and high central venus
      saturations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sepsis remains a common entity in critical care patients with remarkable mortality.
      Microcirculatory dysfunction plays a pivotal role in the pathophysiology of sepsis and organ
      dysfunction. The main causal mechanisms are vasoactive substances such as nitric oxide and
      endothelin, destroyed endothelial surfaces and microvascular occlusion by activated
      coagulation and leucocytes. Furthermore there is some knowledge from vasooclussive testing
      (VOT) based on near-infrared spectroscopy (NIRS) and assessing the proportion of perfused
      vessels determined with orthogonal polarization spectral and sidestream darkfield imaging
      techniques (SDF) that impaired microcirculation is associated with organ dysfunction and
      increased mortality. Despite these well-recognised evidence previous trails proving therapy
      guidance with microcirculatory parameters failed in demonstrating optimised outcome . Recent
      guidelines still recommend fluid therapy based on central venous pressure, mean arterial
      pressure, urine output and or blood lactate concentration. But especially the parameter
      central venous oxygen saturation (ScvO2) seems to be not unproblematic. Retrospective data
      analysis found higher mortality rates if ScvO2 is elevated.

      In the present study patients with sepsis, severe sepsis and septic shock will be evaluated
      on day 1 and day 4 and a follow up will be performed on day 180.

      Additional to clinical parameters of organ function, infection markers, global parameters of
      tissue hypoxia will be captured by measurements of adenosine and whose metabolites.

      Macrocirculatory cardiovascular function delivered by transpulmonary thermodilution technique
      will be assessed and local tissue perfusion and oxygen uptake will be measured with a
      transcutaneous laser-doppler spectrophotometry system in VOT.

      The aim of this study is to check:

        1. Is microcirculatory oxygen uptake a prognostic value in sepsis?

        2. Is it correlated with biomarkers of hypoxia?

        3. Are high levels of ScvO2 caused by microcirculatory impairments or by hyperdynamic
           macrocirculation?
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">August 1, 2017</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>180 days</time_frame>
    <description>ICU-Mortality, 60-days-mortlity, 180-days-mortality will be recorded and correlated with baseline and postischemic microcirculatory oxygen delivery and uptake.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Connection between ScvO2 and microcirculatory oxygen uptake</measure>
    <time_frame>Day 1 and day 4</time_frame>
    <description>The investigators will prove, if high values of central venous saturation (&gt;75%) are associated with impaired tissue oxygen uptake.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Connection between adenosine-metabolites and microcirculatory oxygen uptake</measure>
    <time_frame>Day 1 and day 4</time_frame>
    <description>The investigators will prove, if high values of the adenosine-metabolite hypoxanthine (ng/ml) in plasma are associated with impaired tissue oxygen uptake.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical condition</measure>
    <time_frame>180 days</time_frame>
    <description>Physical status at 180 days (Rankin-Scale) will be recorded and correlated with baseline and postischemic microcirculatory oxygen delivery and uptake.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">102</enrollment>
  <condition>Sepsis</condition>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Vasoocclusive testing in sepsis</arm_group_label>
    <description>Septic patients defined according to the Surviving Sepsis Campaign (SSC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vasoocclusive testing in severe sepsis</arm_group_label>
    <description>Severe septic patients defined according to the Surviving Sepsis Campaign (SSC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vasoocclusive testing in sepsic shock</arm_group_label>
    <description>Septic shock patients defined according to the Surviving Sepsis Campaign (SSC)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vasoocclusive testing</intervention_name>
    <description>Forearm vasoocclusive testing with a laser-doppler spectrophotometry system, transpulmonary thermodilution and blood sampling;</description>
    <arm_group_label>Vasoocclusive testing in sepsis</arm_group_label>
    <arm_group_label>Vasoocclusive testing in severe sepsis</arm_group_label>
    <arm_group_label>Vasoocclusive testing in sepsic shock</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted a surgical intensive care unit within the last 24 hours and the diagnosis
        of sepsis, severe sepsis and septic shock according to the Surviving Sepsis Campaign.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Criteria according to the SSC for sepsis, severe sepsis and septic shock

          -  Admission to the ICU within 24 hours

        Exclusion Criteria:

          -  Pregnancy

          -  Cardiopulmonary resuscitation within the last 5 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manfred Thiel, Prof. Dr. med.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre of Mannheim</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Centre, Department of Anaesthesiology and Surgical Intensive Care Medicine</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013 Aug 29;369(9):840-51. doi: 10.1056/NEJMra1208623. Review. Erratum in: N Engl J Med. 2013 Nov 21;369(21):2069.</citation>
    <PMID>23984731</PMID>
  </reference>
  <reference>
    <citation>De Backer D, Donadello K, Cortes DO. Monitoring the microcirculation. J Clin Monit Comput. 2012 Oct;26(5):361-6. doi: 10.1007/s10877-012-9383-8. Epub 2012 Jul 26. Review.</citation>
    <PMID>22833180</PMID>
  </reference>
  <reference>
    <citation>Shapiro NI, Arnold R, Sherwin R, O'Connor J, Najarro G, Singh S, Lundy D, Nelson T, Trzeciak SW, Jones AE; Emergency Medicine Shock Research Network (EMShockNet). The association of near-infrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit Care. 2011;15(5):R223. doi: 10.1186/cc10463. Epub 2011 Sep 22.</citation>
    <PMID>21939529</PMID>
  </reference>
  <reference>
    <citation>Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004 Sep;32(9):1825-31.</citation>
    <PMID>15343008</PMID>
  </reference>
  <reference>
    <citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.</citation>
    <PMID>23353941</PMID>
  </reference>
  <reference>
    <citation>Textoris J, Fouché L, Wiramus S, Antonini F, Tho S, Martin C, Leone M. High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Crit Care. 2011 Jul 26;15(4):R176. doi: 10.1186/cc10325.</citation>
    <PMID>21791065</PMID>
  </reference>
  <reference>
    <citation>van der Voort PH, van Zanten M, Bosman RJ, van Stijn I, Wester JP, van Raalte R, Oudemans-van Straaten HM, Zandstra DF. Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot study. Eur J Anaesthesiol. 2015 Mar;32(3):189-98. doi: 10.1097/EJA.0000000000000126.</citation>
    <PMID>25032942</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2015</study_first_submitted>
  <study_first_submitted_qc>April 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2015</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Timo Sturm</investigator_full_name>
    <investigator_title>Dr. med. Timo Sturm, DESA</investigator_title>
  </responsible_party>
  <keyword>microcirculation</keyword>
  <keyword>oxygen uptake</keyword>
  <keyword>hypoxia</keyword>
  <keyword>adenosine</keyword>
  <keyword>central venous saturation</keyword>
  <keyword>hypoxanthine</keyword>
  <keyword>laserdoppler</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

